Walgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores

"LabCorp at Walgreens" Sites Will Provide Specimen Collection Services for LabCorp Testing Seven Service Centers Planned to Open at Walgreens Stores in 2017 DEERFIELD, Ill. & BURLINGTON, N.C.--( BUSINESS WIRE )--Walgreens and LabCorp® (NYSE: LH) today announced a collaboration through which

Covance Opens State-of-the-Art Laboratory for Companion Diagnostics

Dedicated Facility Furthers the Unmatched Value of the Combined Expertise of Covance Drug Development and LabCorp Diagnostics to Advance Precision Medicine BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 14, 2017-- LabCorp® (NYSE:LH), a leading global life sciences company, announced today that its

LabCorp Exclusively Launches Sera Prognostics’ PreTRM Test to Assess for Risk of Preterm Birth

The PreTRM Test is the Only Validated Test That Provides Early and Individualized Evaluation of Preterm Birth Risk BURLINGTON, N.C. --(BUSINESS WIRE)--May 23, 2017-- LabCorp® (NYSE: LH) today announced the nationwide availability of the PreTRM® test. Developed by Sera Prognostics, Inc.

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 9, 2017-- LabCorp® (NYSE: LH) today announced it will participate at the Bank of America Merrill Lynch 2017 Health Care Conference . LabCorp’s presentation is scheduled for Tuesday, May 16, 2017 , at 10:40 a.m. PT .

LabCorp Completes Acquisition of Pathology Associates Medical Laboratories

Transaction Establishes Relationships with Community-Based Health Systems Across Multiple States BURLINGTON, N.C. & RENTON, Wash. & ENGLEWOOD, Colo.--( BUSINESS WIRE )--LabCorp® (NYSE:LH) has completed the acquisition of Pathology Associates Medical Laboratories (PAML) from former owners

LabCorp to Webcast Its Annual Meeting of Shareholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May 4, 2017-- LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, 2017 at 9:00 a.m. Eastern Daylight Time via the Company website at www.labcorp.com . An archived replay of the audio webcast will be

LabCorp Enhances VistaSeq Hereditary Cancer Test Portfolio with Addition of New Panels and New Genes That Can Be Assessed

Expanded Test Offering Provides Targeted Insight into Risk for Hereditary Cancer Syndromes BURLINGTON, N.C. --(BUSINESS WIRE)--May 3, 2017-- LabCorp® (NYSE: LH) today announced a significant enhancement to its proprietary VistaSeq SM Hereditary Cancer portfolio, with ten new test panels focusing on

LabCorp’s Acquisition of Pathology Associates Medical Laboratories Clears Antitrust Review

BURLINGTON, N.C. --(BUSINESS WIRE)--May 1, 2017-- LabCorp® (NYSE: LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to LabCorp’s acquisition of Pathology Associates Medical Laboratories, LLC (PAML) has expired.

LabCorp Completes Acquisition of Assets of Mount Sinai Health System Clinical Outreach Laboratories

Transaction will benefit physicians and patients in metropolitan New York City BURLINGTON, N.C. --(BUSINESS WIRE)--May 1, 2017-- LabCorp ® (NYSE: LH), a leading global life sciences company, has completed the previously announced acquisition of assets of the Mount Sinai Health System Clinical

LabCorp to Exclusively Offer the M3 Checklist, a Multi-Condition Mental Health Screening Tool

The M3 Checklist Helps to Identify and Monitor Common Mental Health Conditions in the Primary Care Setting BURLINGTON, N.C. & ROCKVILLE, Md. --(BUSINESS WIRE)--Apr. 28, 2017-- LabCorp ® (NYSE:LH) and M-3 Information, LLC today announced the nationwide availability through LabCorp of the